Good morning! After a two-year dry spell, initial public offerings by biotech companies showed signs of life during the first three months of 2024.Sign up for NBC San Diego newsletters.
The Fed's interest rate hikes were a big driver of the downturn, according to Perrone. He said the poor performance of new publicly traded companies also contributed, specifically due to a higher number of clinical trial failures. But the bottom line is that we'll have to keep"rate-watching" to see what the pace of biotech IPO activity will look like moving forward, Perrone said. Stay tuned for our coverage in this area.Hands, tablet and doctor with body hologram, overlay and dna research for medical innovation on app.
XRAIL was founded last year to help anesthesiologists and anesthesiologists-in-training hone their abilities. Jotwani and Rubin believe tech like virtual reality and artificial intelligence can improve medical education and clinical practice within the specialty. The experience was immersive as soon as I put on the headset. Once we all joined the session, I could see Jotwani and Cherenfant's avatars, as well as a 3D model of a spine in the middle of the room. Cherenfant and I watched as Jotwani made the model bigger and smaller, picked up individual bones and muscles, turned them at different angles and drew in the air.
While XRAIL is using VR to help teach technical skills like how to carry out procedures, it is also using AI to teach soft skills like how to speak to and listen to patients. Jotwani and Rubin, who are not engineers by background, have built around 10 different AI-powered conversational agents that doctors can practice speaking with in real time.